| Code | CSB-RA006595MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to the reference antibody described in US20140199312, specifically targeting DDR1 (Discoidin Domain Receptor 1). DDR1 is a receptor tyrosine kinase that binds to various types of collagen in the extracellular matrix, playing crucial roles in cell adhesion, migration, proliferation, and differentiation. This receptor is particularly significant in tissue remodeling and wound healing processes. Aberrant DDR1 expression and activation have been implicated in multiple pathological conditions, including fibrotic diseases, atherosclerosis, and various cancers where it contributes to tumor progression, metastasis, and chemotherapy resistance.
The reference antibody disclosed in US20140199312 represents a well-characterized tool for investigating DDR1 biology and its involvement in disease mechanisms. This biosimilar antibody provides researchers with a reliable reagent for studying DDR1-mediated signaling pathways, exploring its role in collagen-dependent cellular processes, and investigating therapeutic strategies targeting DDR1 in oncology and fibrosis research. It serves as a valuable tool for advancing understanding of DDR1 function in both normal physiology and disease states.
There are currently no reviews for this product.